Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility
Article in Clinical Orthopaedics and Related Research® (May 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Reduction of New Heterotopic Ossification (HO) in the Open‐Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)
Article in Journal of Bone and Mineral Research (January 2023)
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery
Article in Nature Communications (October 2022)